[1]Bolli R, Tang XL, Sanganalmath SK, et al. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy[J]. Circulation,2013, 128(2): 122-131.
[2]Lamata P, Sinclair M, Kerfoot E,et al. An automatic service for the personalization of ventricular cardiac meshes[J]. J R Soc Interface, 2013,11(91): 20131023.
[3]Davies MJ.The cardiomyopathies: an overview[J].Heart, 2000, 83(4): 469-474.
[4]Efthimiadis GK, Pagourelias ED, Gossios T, et al. Hypertrophic cardiomyopathy in 2013: current speculations and future perspectives[J]. World J Cardiol, 2014,6(2): 26-37.
[5]Higaki JN, Chakrabartty A, Galant NJ, et al. Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin[J].Amyloid,2016, 23(2): 86-97.
[6]Guertl B, Noehammer C, Hoefler G. Metabolic cardiomyopathies[J]. Int J Exp Pathol, 2000, 81(6): 349-372.
[7]Ren K, Yuan J, Yang M, et al. KCTD10 is involved in the cardiovascular system and Notch signaling during early embryonic development[J]. PLoS One,2014,9(11):e112275.
[8]Creemers EE, Wilde AA, Pinto YM. Heart failure: advances through genomics[J]. Nat Rev Genet,2011,12(5):357-362.
[9]Greco S, Zaccagnini G, Perfetti A,et al.Long noncoding RNA-dysregulation in ischemic heart failure[J]. J Transl Med, 2016,14(1):183.
|